U.S. Renal Care
Dialysis and renal care provider
Based in TX
🤖
AI Overview
With $1.4M in lobbying spend across 27 quarterly filings, U.S. Renal Care is a significant lobbying presence.
$1.4M
Total Lobbying Spend
27
Quarterly Filings
1
Lobbying Firms Used
10
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $100K |
| 2019 | $100K |
| 2020 | $200K |
| 2021 | $200K |
| 2022 | $150K |
| 2023 | $200K |
| 2024 | $200K |
| 2025 | $200K |
Lobbying Firms
JEFFREY J. KIMBELL & ASSOCIATES, INC.
What They Lobby For
- HR 3976, Access to Marketplace Insurance Act
- Issues related to Medicare coverage of ESRD and charitable premium assistance.
- HR 4143, Dialysis PATIENTS Demonstration Act; issues related to Medicare policies impacting ESRD; charitable premium assistance
- Access to Marketplace Insurance Act/charitable premium assistance
- Issues related to Medicare policies impacting ESRD; charitable premium assistance; integrated kidney care; alternative payment models
- Issues related to Medicare policies impacting ESRD; charitable premium assistance; integrated kidney care; alternative payment models; Medicare Advantage; issues related to COVID-19 public health emergency
- Access to Marketplace Insurance Act/charitable premium assistance; issues related to COVID-19 public health emergency
- Charitable premium assistance; issues related to COVID-19 public health emergency
- issues related to Medicare policies impacting ESRD; charitable premium assistance; integrated kidney care; alternative payment models; Medicare Advantage; issues related to COVID-19 public health emergency
- extreme weather emergency response
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.